PIMJS
PKO Investment Management Joint-Stock Portfolio holdings
AUM
$931M
This Quarter Return
+13.07%
1 Year Return
+16.38%
3 Year Return
+65%
5 Year Return
+112.48%
10 Year Return
+522.82%
AUM
$931M
AUM Growth
+$931M
(+5.6%)
Cap. Flow
-$71.4M
Cap. Flow
% of AUM
-7.67%
Top 10 Holdings %
Top 10 Hldgs %
40.41%
Holding
182
New
8
Increased
48
Reduced
68
Closed
7
Top Buys
| 1 |
Apple
AAPL
|
$15M |
| 2 |
T-Mobile US
TMUS
|
$11.9M |
| 3 |
Intuitive Surgical
ISRG
|
$8.1M |
| 4 |
Amgen
AMGN
|
$7.44M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$5.21M |
Top Sells
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
$32.9M |
| 2 |
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
|
$31.5M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$29.7M |
| 4 |
Microsoft
MSFT
|
$10.9M |
| 5 |
Broadcom
AVGO
|
$8.27M |
Sector Composition
| 1 | Technology | 27.09% |
| 2 | Materials | 15.29% |
| 3 | Healthcare | 13.03% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
HCA Healthcare
HCA
$94.5B
| $651K | 0.07% |
1,700
-1,600
| -48% | -$613K |
|
152
Coterra Energy
CTRA
$18.7B
| $584K | 0.06% |
23,000
| – | – |
|
|
CGAU
153
Centerra Gold
CGAU
$1.66B
| $567K | 0.06% |
79,000
-66,000
| -46% | -$473K |
|
154
Devon Energy
DVN
$22.9B
| $562K | 0.06% |
17,661
+4,000
| +29% | +$127K |
|
155
CF Industries
CF
$14B
| $524K | 0.06% |
5,700
| – | – |
|
156
BioMarin Pharmaceuticals
BMRN
$11.2B
| $495K | 0.05% |
9,000
| – | – |
|
157
Rivian
RIVN
$16.5B
| $495K | 0.05% |
36,000
| – | – |
|
|
AAUC
158
Allied Gold Corporation
AAUC
$1.62B
| $495K | 0.05% |
+37,000
| New | +$495K |
|
159
McKesson
MCK
$85.4B
| $440K | 0.05% |
600
-900
| -60% | -$660K |
|
160
Hyatt Hotels
H
$13.8B
| $419K | 0.05% |
3,000
| – | – |
|
|
DRD
161
DRDGold
DRD
$1.59B
| $384K | 0.04% |
28,814
-22,000
| -43% | -$293K |
|
162
Idexx Laboratories
IDXX
$51.8B
| $375K | 0.04% |
700
-2,600
| -79% | -$1.39M |
|
163
Viatris
VTRS
$12.3B
| $357K | 0.04% |
40,000
| – | – |
|
164
Illumina
ILMN
$15.8B
| $334K | 0.04% |
3,500
| – | – |
|
165
Ovintiv
OVV
$10.8B
| $323K | 0.03% |
8,500
| – | – |
|
166
Veeva Systems
VEEV
$44B
| $288K | 0.03% |
1,000
-1,000
| -50% | -$288K |
|
167
RH
RH
$4.23B
| $284K | 0.03% |
1,500
| – | – |
|
168
Signet Jewelers
SIG
$3.62B
| $278K | 0.03% |
3,500
-3,500
| -50% | -$278K |
|
169
Viking Therapeutics
VKTX
$3.04B
| $265K | 0.03% |
10,000
-5,000
| -33% | -$133K |
|
170
Teladoc Health
TDOC
$1.37B
| $261K | 0.03% |
30,000
| – | – |
|
171
Brown-Forman Class B
BF.B
$14.2B
| $242K | 0.03% |
9,000
| – | – |
|
172
PVH
PVH
$4.05B
| $172K | 0.02% |
2,500
-2,500
| -50% | -$172K |
|
173
Moderna
MRNA
$9.37B
| $166K | 0.02% |
6,000
| – | – |
|
174
Capri Holdings
CPRI
$2.45B
| $133K | 0.01% |
7,500
-7,500
| -50% | -$133K |
|
175
Baxter International
BAX
$12.7B
| $121K | 0.01% |
4,000
| – | – |
|